Treatment of Inflammatory Bowel Disease in the Older Patient

被引:4
|
作者
Dorreen, Alastair [1 ]
Heisler, Courtney [2 ]
Jones, Jennifer [2 ,3 ]
机构
[1] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[2] Dalhousie Univ, Dept Med, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Epidemiol & Biostat, Halifax, NS, Canada
关键词
advanced age; Crohn's disease; inflammatory bowel disease; treatment; adverse events; POPULATION-BASED COHORT; ANTI-TNF THERAPY; CLINICAL-PRACTICE GUIDELINES; POUCH-ANAL ANASTOMOSIS; LOW-GRADE DYSPLASIA; CROHNS-DISEASE; ULCERATIVE-COLITIS; ELDERLY-PATIENTS; MAINTENANCE THERAPY; COLORECTAL-CANCER;
D O I
10.1093/ibd/izy023
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The incidence of inflammatory bowel disease (IBD) is increasing, and as our population ages, there is a growing number of IBD patients who are transitioning into advanced age; 15% to 20% of IBD patients are classified as late-onset (between 60-65 years of age). This has led clinicians to treat a large number of older patients with IBD. The principles of management of IBD in older patients are the same as those who are younger. There are, however, phenotypic differences that are unique to late-onset IBD and age-related concerns that clinicians must consider when initiating therapy for their older patients with IBD. Given the increasing number of older IBD patients, the aim of this article is to present an updated, evidence-based review of the therapeutic options and issues that arise in this unique patient population.
引用
收藏
页码:1155 / 1166
页数:12
相关论文
共 50 条
  • [31] Patient with proctitis: inflammatory bowel disease or infectious disease?
    Esitgen Germaner E.T.
    Seybold U.
    MMW - Fortschritte der Medizin, 2024, 166 (Suppl 2) : 45 - 46
  • [32] Use of Infliximab for the Treatment of Sweet's Syndrome in a Patient with Inflammatory Bowel Disease
    Patel, Anish V.
    Jotwani, Pooja
    Desai, Deepak
    Sultan, Keith
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S832 - S832
  • [33] Patient perception towards faecal microbiota transplantation for treatment of Inflammatory Bowel Disease
    Quraishi, N.
    McMillan, M.
    Widlak, M.
    Nell, L.
    Quraishi, K.
    Pathmakanthan, S.
    Sharma, N.
    Iqbal, T.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S252 - S252
  • [34] Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine
    Puga, Manuel
    Carpio, Daniel
    Sampil, Marta
    Jose Zamora, Maria
    Fernandez-Salgado, Estela
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (07) : 610 - 610
  • [35] Treatment of Inflammatory Bowel Disease: Is your Patient at Risk of Non-Adherence?
    Magalhaes, Joana
    De Castro, Francisca Dias
    Carvalho, Pedro Boal
    Leite, Silvia
    Moreira, Maria Joao
    Cotter, Jose
    ACTA MEDICA PORTUGUESA, 2014, 27 (05): : 576 - 580
  • [36] Abdominal Pain in a Patient With Diverted Bowel and Inflammatory Bowel Disease
    Hasan, Badar
    Khalid, Rumman
    Charles, Roger
    Shen, Bo
    ACG CASE REPORTS JOURNAL, 2020, 7 (08)
  • [37] Patient and Gastroenterologist Attitudes of Fecal Microbiota Transplantation as a Treatment for Inflammatory Bowel Disease
    Dunleavy, Katie A.
    Stanley, Stephanie
    Hirten, Robert
    Sands, Bruce E.
    Grinspan, Ari M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S450 - S450
  • [38] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Haddley, K.
    DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
  • [39] Cannabis for the Treatment of Inflammatory Bowel Disease
    Nattali, Timna
    Halt, Elizabeth
    Yablecovitch, Doron
    Konikoff, Fred M.
    GASTROENTEROLOGY, 2010, 138 (05) : S699 - S699
  • [40] Probiotics in the treatment of inflammatory bowel disease
    Rioux, KP
    Fedorak, RN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (03) : 260 - 263